A DR4:tBID axis drives the p53 apoptotic response by promoting oligomerization of poised BAX

被引:29
作者
Henry, Ryan E. [1 ]
Andrysik, Zdenek [1 ]
Paris, Ramiro [1 ]
Galbraith, Matthew D. [1 ]
Espinosa, Joaquin M. [1 ]
机构
[1] Univ Colorado, Dept Mol Cellular & Dev Biol, Howard Hughes Med Inst, Boulder, CO 80309 USA
关键词
apoptosis; BAX; cell fate choice; DR4; p53; TUMOR-SUPPRESSOR P53; COLORECTAL-CANCER CELLS; IN-VIVO; DNA-DAMAGE; TARGET GENES; TRANSCRIPTIONAL REGULATION; PUMA; EXPRESSION; DEATH; ACTIVATION;
D O I
10.1038/emboj.2011.498
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The cellular response to p53 activation varies greatly in a stimulus- and cell type-specific manner. Dissecting the molecular mechanisms defining these cell fate choices will assist the development of effective p53-based cancer therapies and also illuminate fundamental processes by which gene networks control cellular behaviour. Using an experimental system wherein stimulus-specific p53 responses are elicited by non-genotoxic versus genotoxic agents, we discovered a novel mechanism that determines whether cells undergo proliferation arrest or cell death. Strikingly, we observe that key mediators of cell-cycle arrest (p21, 14-3-3r) and apoptosis (PUMA, BAX) are equally activated regardless of outcome. In fact, arresting cells display strong translocation of PUMA and BAX to the mitochondria, yet fail to release cytochrome C or activate caspases. Surprisingly, the key differential events in apoptotic cells are p53-dependent activation of the DR4 death receptor pathway, caspase 8-mediated cleavage of BID, and BID-dependent activation of poised BAX at the mitochondria. These results reveal a previously unappreciated role for DR4 and the extrinsic apoptotic pathway in cell fate choice following p53 activation. The EMBO Journal (2012) 31, 1266-1278. doi:10.1038/emboj.2011.498; Published online 13 January 2012
引用
收藏
页码:1266 / 1278
页数:13
相关论文
共 56 条
[31]  
MIYASHITA T, 1994, ONCOGENE, V9, P1799
[32]   Regulation of the p53 transcriptional response by structurally diverse core promoters [J].
Morachis, Jose M. ;
Murawsky, Christopher M. ;
Emerson, Beverly M. .
GENES & DEVELOPMENT, 2010, 24 (02) :135-147
[33]   p53 activates the CD95 (APO-1/Fas) gene in response to DNA damage by anticancer drugs [J].
Müller, M ;
Wilder, S ;
Bannasch, D ;
Israeli, D ;
Lehlbach, K ;
Li-Weber, M ;
Friedman, SL ;
Galle, PR ;
Stremmel, W ;
Oren, M ;
Krammer, PH .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (11) :2033-2045
[34]   PUMA, a novel proapoptotic gene, is induced by p53 [J].
Nakano, K ;
Vousden, KH .
MOLECULAR CELL, 2001, 7 (03) :683-694
[35]   Isolation and subfractionation of mitochondria from animal cells and tissue culture lines [J].
Pallotti, Francesco ;
Lenaz, Giorgio .
MITOCHONDRIA, 2ND EDITION, 2007, 80 :3-44
[36]   Multiple p53-independent gene silencing mechanisms define the cellular response to p53 activation [J].
Paris, Ramiro ;
Henry, Ryan E. ;
Stephens, Sarah J. ;
McBryde, Meagan ;
Espinosa, Joaquin M. .
CELL CYCLE, 2008, 7 (15) :2427-2433
[37]   ASPP proteins specifically stimulate the apoptotic function of p53 [J].
Samuels-Lev, Y ;
O'Connor, DJ ;
Bergamaschi, D ;
Trigiante, G ;
Hsieh, JK ;
Zhong, S ;
Campargue, I ;
Naumovski, L ;
Crook, T ;
Lu, X .
MOLECULAR CELL, 2001, 8 (04) :781-794
[38]   BID regulation by p53 contributes to chemosensitivity [J].
Sax, JK ;
Fei, PW ;
Murphy, ME ;
Bernhard, E ;
Korsmeyer, SJ ;
El-Deiry, WS .
NATURE CELL BIOLOGY, 2002, 4 (11) :842-849
[39]   p53 triggers apoptosis in oncogene-expressing fibroblasts by the induction of Noxa and mitochondrial Bax translocation [J].
Schuler, M ;
Maurer, U ;
Goldstein, JC ;
Breitenbücher, F ;
Hoffarth, S ;
Waterhouse, NJ ;
Green, DR .
CELL DEATH AND DIFFERENTIATION, 2003, 10 (04) :451-460
[40]   Acetylation of the p53 DNA-binding domain regulates apoptosis induction [J].
Sykes, Stephen M. ;
Mellert, Hestia S. ;
Holbert, Marc A. ;
Li, Keqin ;
Marmorstein, Ronen ;
Lane, William S. ;
McMahon, Steven B. .
MOLECULAR CELL, 2006, 24 (06) :841-851